Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Stem Cell Engineering Technology Research Center is a prominent biotechnology institution based in Jinan, China, specializing in the research, storage, and clinical application of stem cells. Operated by Shandong Qilu Stem Cell Engineering Co., Ltd., the center serves as the technical foundation for the Shandong Cord Blood Bank, one of the few licensed facilities of its kind in the country. Its core operations include the cryopreservation of umbilical cord blood, umbilical cord, and placental tissues, alongside the development of mesenchymal stem cell (MSC) therapies. The center is actively involved in clinical research for regenerative medicine, targeting conditions such as liver cirrhosis, diabetes, and various hematological disorders. Through its integration of biobanking and therapeutic development, it plays a critical role in the regional life sciences ecosystem in Shandong province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Stem Cell Engineering Technology Research Center.